Cargando…
High-dose budesonide for early COVID-19
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660033/ https://www.ncbi.nlm.nih.gov/pubmed/34895529 http://dx.doi.org/10.1016/S0140-6736(21)02440-5 |
_version_ | 1784613103784165376 |
---|---|
author | Lipworth, Brian Chan, Rory Misirovs, Rasads |
author_facet | Lipworth, Brian Chan, Rory Misirovs, Rasads |
author_sort | Lipworth, Brian |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8660033 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86600332021-12-10 High-dose budesonide for early COVID-19 Lipworth, Brian Chan, Rory Misirovs, Rasads Lancet Correspondence Elsevier Ltd. 2021 2021-12-09 /pmc/articles/PMC8660033/ /pubmed/34895529 http://dx.doi.org/10.1016/S0140-6736(21)02440-5 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence Lipworth, Brian Chan, Rory Misirovs, Rasads High-dose budesonide for early COVID-19 |
title | High-dose budesonide for early COVID-19 |
title_full | High-dose budesonide for early COVID-19 |
title_fullStr | High-dose budesonide for early COVID-19 |
title_full_unstemmed | High-dose budesonide for early COVID-19 |
title_short | High-dose budesonide for early COVID-19 |
title_sort | high-dose budesonide for early covid-19 |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660033/ https://www.ncbi.nlm.nih.gov/pubmed/34895529 http://dx.doi.org/10.1016/S0140-6736(21)02440-5 |
work_keys_str_mv | AT lipworthbrian highdosebudesonideforearlycovid19 AT chanrory highdosebudesonideforearlycovid19 AT misirovsrasads highdosebudesonideforearlycovid19 |